Abstract
Implantable medical devices remain as one of the major research areas because of their potential applications in health care. The targeted, controlled delivery of a drug by an implantable device is an optimum therapy to treat a range of conditions. For example, coronary stenting presents both the need and the opportunity for local drug delivery. Various classes of implantable devices are listed in this chapter. This chapter focuses on requirements of implantable devices such as mechanical properties which are essential for structural support, types and prevention methods of corrosion, biocompatibility of devices and sterilisation to prevent implant associated infections. Properties of metallic, ceramic and polymeric biomaterials used in the manufacturing of implantable devices are also emphasised. Drug delivery applications of cardiovascular and orthopaedic implantable devices are discussed in detail.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- MEMS:
-
Microelectromechanical systems
- NEMS:
-
Nano-electromechanical systems
- PCL:
-
Polycaprolactone
- PET:
-
Polyethylene terephthalate
- PGA:
-
Polyglycolic acid
- PLA:
-
Polylactic acid
- PU:
-
Polyurethane
- PTFE:
-
Poly(tetrafluoroethylene)
- PMMA:
-
Polymethylmethacrylate
- UHMWPE:
-
Ultrahigh molecular weight polyethylene
References
Regar E, Sianos G, Serruys PW (2001) Stent development and local drug delivery. Br Med Bull 59:227–248
Ginebra MP, Traykova T, Planell JA (2006) Calcium phosphate cements as bone drug delivery systems: a review. J Control Release 113:102–110
Long M, Rack HJ (1998) Titanium alloys in total joint replacement-a materials science perspective. Biomaterials 19:1621–1639
Gultepe E, Nagesha D, Sridhar S, Amiji M (2010) Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices. Adv Drug Deliv Rev 62:305–315
Park GE, Webster TJ (2005) A review of nanotechnology for the development of better orthopedic implants. J Biomed Nanotechnol 1:18–29
Gunn J, Cumberland D (1999) Stent coatings and local drug delivery. State of the art. Eur Heart J 20:1693–1700
Zuckerman DM, Brown P, Nissen SE (2011) Medical device recalls and the FDA approval process. Arch Intern Med 171:1006–1018
Santos MH, Valerio P, Goes AM, Leite MF, Heneine LGD, Mansur HS (2007) Biocompatibility evaluation of hydroxyapatite/collagen nanocomposites doped with Zn+2. Biomed Mater 2:135
Jung F, Wischke C, Lendlein A (2010) Degradable, multifunctional cardiovascular implants: challenges and hurdles. MRS Bull 35:607–613
Ajili SH, Ebrahimi NG, Soleimani M (2009) Polyurethane/polycaprolactane blend with shape memory effect as a proposed material for cardiovascular implants. Acta Biomater 5:1519–1530
Wischke C, Lendlein A (2011) Designing multifunctional polymers for cardiovascular implants. Clin Hemorheol Microcirc 49:347–355
Andukuri A, Kushwaha M, Tambralli A, Anderson JM, Dean DR, Berry JL et al (2011) A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants. Acta Biomater 7:225–233
Kelly A (1990) Concise encyclopedia of composite materials. MIT Press, Cambridge
Balkany TJ, Hodges AV, Eshraghi AA, Butts S, Bricker K, Lingvai J et al (2002) Cochlear implants in children—a review. Acta Otolaryngol 122:356–362
Yasukawa T, Ogura Y, Sakurai E, Tabata Y, Kimura H (2005) Intraocular sustained drug delivery using implantable polymeric devices. Adv Drug Deliv Rev 57:2033–2046
Choonara YE, Pillay V, Danckwerts MP, Carmichael TR, du Toit LC (2010) A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases. J Pharm Sci 99:2219–2239
Williams DF (2009) On the nature of biomaterials. Biomaterials 30:5897–5909
Williams D (2008) The relationship between biomaterials and nanotechnology. Biomaterials 29:1737
Khan W, Kapoor M, Kumar N (2007) Covalent attachment of proteins to functionalized polypyrrole-coated metallic surfaces for improved biocompatibility. Acta Biomater 3:541–549
Khan W, Marew T, Kumar N (2006) Immobilization of drugs and biomolecules on in situ copolymerized active ester polypyrrole coatings for biomedical applications. Biomed Mater 1:235–241
Agrawal CM (1998) Reconstructing the human body using biomaterials. J Miner Met Mater Soc 50:31–35
Davis JR (2003) Handbook of materials for medical devices. ASM International, Materials Park, OH
Rack HJ, Qazi JI (2006) Titanium alloys for biomedical applications. Mater Sci Eng C 26:1269–1277
Roach M (2007) Base metal alloys used for dental restorations and implants. Dent Clin N Am 51:603–627
BomBac DD, Brojan M, Fajfar P, Kosel F, Turk R (2007) Review of materials in medical applications. RMZ Mater Geoenviron 54:471–499
Angelova N, Hunkeler D (1999) Rationalizing the design of polymeric biomaterials. Trends Biotechnol 17:409–421
Venkatraman S, Boey F, Lao LL (2008) Implanted cardiovascular polymers: natural, synthetic and bio-inspired. Prog Polym Sci 33:853–874
Commandeur S, Van Beusekom HMM, Van Der Giessen WIMJ (2006) Polymers, drug release, and drug eluting stents. J Interv Cardiol 19:500–506
Metzger A (1976) Polyethylene terephthalate and the pillarTM palatal implant: its historical usage and durability in medical applications. Biomed Eng 11:301–306
Lyu SP, Untereker D (2009) Degradability of polymers for implantable biomedical devices. Int J Mol Sci 10:4033–4065
Gogolewski S (2000) Bioresorbable polymers in trauma and bone surgery. Injury 31:D28–D32
Santos AR Jr (2010) Bioresorbable polymers for tissue engineering. In: Eberlin D (ed) Tissue engineering. In-Teh, Olajnica, pp 235–246
Middleton JC, Tipton AJ (2000) Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21:2335–2346
Geiger M, Li RH, Friess W (2003) Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55:1613–1629
Patino MG, Neiders ME, Andreana S, Noble B, Cohen RE (2002) Collagen as an implantable material in medicine and dentistry. J Oral Implantol 28:220–225
Ramshaw JAM, Werkmeister JA, Glattauer V (1995) Collagen-based biomaterials. Biotechnol Genet Eng Rev 13:335–382
Roohpour N, Wasikiewicz JM, Paul D, Vadgama P, Rehman IU (2009) Synthesis and characterisation of enhanced barrier polyurethane for encapsulation of implantable medical devices. J Mater Sci Mater Med 20:1803–1814
Diener T, Hensel B, Heublein B, Barlach S, Rohde R, Sternberg K et al (2003) Biodegradable drug depots on coronary stents-local drug delivery in interventional cardiology. Prog Biomed Res 8:82–91
Khan W, Farah S, Domb AJ (2012) Drug eluting stents: developments and current status. J Control Release 161:703���712
Levy Y, Khan W, Farah S, Domb AJ (2012) Surface crystallization of rapamycin on stents using a temperature induced process. Langmuir 28:6207–6210
Wu P, Grainger DW (2006) Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 27:2450–2467
Nag S, Banerjee R (2012) Fundamentals of Medical Implant Materials. In: Narayan R (eds) Materials for medical devices. ASM International, pp 6–16
Dujovne AR, Bobyn JD, Krygier JJ, Miller JE, Brooks CE (1993) Mechanical compatibility of noncemented hip prostheses with the human femur. J Arthroplasty 8:7–22
Sumner DR, Galante JO (1992) Determinants of stress shielding: design versus materials versus interface. Clin Orthop Relat Res 274:202–212
Kamachimudali U, Sridhar TM, Raj B (2003) Corrosion of bio implants. In: Sadhana: Academy proceedings in engineering sciences. Indian Academy of Sciences, pp 601–637
Black J (1988) Orthopaedic biomaterials in research and practice. Churchill Livingstone, New York, NY
Jacobs JJ, Gilbert JL, Urban RM (1998) Current concepts review-corrosion of metal orthopaedic implants. J Bone Joint Surg Am 80:268–282
Hallab NJ, Urban RM, Jacobs JJ (2004) Corrosion and biocompatibility of orthopedic implants. In: Yaszemski MJ, Trantolo DJ, Lewandrowski KU, Hasici V, Altobelli DE, Wise DL (eds) Biomaterials in orthopedics. Dekker, New York, NY, p 75
Williams DF (2008) On the mechanisms of biocompatibility. Biomaterials 29:2941–2953
Onuki Y, Bhardwaj U, Papadimitrakopoulos F, Burgess DJ (2008) A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response. J Diabetes Sci Technol 2:1003–1015
Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (2004) Biomaterials science: an introduction to materials in medicine. Academic, San Diego, CA
Kirkpatrick CJ, Peters K, Hermanns M, Bittinger F, Krump-Konvalinkova V, Fuchs S et al (2005) In vitro methodologies to evaluate biocompatibility: status quo and perspective. ITBM-RBM 26:192–199
Matthews IP, Gibson C, Samuel AH (1994) Sterilisation of implantable devices. Clin Mater 15:191–215
Band JD, Maki DG (1979) Infections caused by arterial catheters used for hemodynamic monitoring. Am J Med 67:735–741
Rae T (1975) A study on the effects of particulate metals of orthopaedic interest on murine macrophages in vitro. J Bone Joint Surg Br 57:444–450
Foraker AB, Walczak RJ, Cohen MH, Boiarski TA, Grove CF, Swaan PW (2003) Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers. Pharm Res 20:110–116
Losic D, Cole MA, Dollmann B, Vasilev K, Griesser HJ (2008) Surface modification of nanoporous alumina membranes by plasma polymerization. Nanotechnology 19:245704
Tao SL, Desai TA (2003) Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev 55:315–328
Grayson ACR, Shawgo RS, Johnson AM, Flynn NT, Li Y, Cima MJ et al (2004) A BioMEMS review: MEMS technology for physiologically integrated devices. Proc IEEE 92:6–21
Ekinci KL, Roukes ML (2005) Nanoelectromechanical systems. Rev Sci Instrum 76:061101–061112
Grayson ACR, Choi IS, Tyler BM, Wang PP, Brem H, Cima MJ et al (2003) Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater 2:767–772
Finkelstein A, McClean D, Kar S, Takizawa K, Varghese K, Baek N et al (2003) Local drug delivery via a coronary stent with programmable release pharmacokinetics. Circulation 107:777–784
Luginbuehl V, Meinel L, Merkle HP, Gander B (2004) Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 58:197–208
Leach JK, Mooney DJ (2004) Bone engineering by controlled delivery of osteoinductive molecules and cells. Expert Opin Biol Ther 4:1015–1027
Schmitt JM, Hwang K, Winn SR, Hollinger JO (2005) Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 17:269–278
Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL et al (2011) A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a prospective, randomized, multicenter trial to assess an everolimus-eluting coronary stent system [PROMUS element] for the treatment of up to two de novo coronary artery lesions) trial. J Am Coll Cardiol 57:1700–1708
Jaff MR (2012) Advances in the management of patients with vascular disease. Expert Rev Cardiovasc Ther 10:151–153
Kretz B, Steinmetz E, Brenot R, Bouchot O (2012) First results of clampless distal anastomosis in peripheral vascular bypass with LeGoo, a thermoreversible polymer. J Vasc Surg 55:1821–1825
Kennedy DW (2012) The PROPELTM steroid-releasing bioabsorbable implant to improve outcomes of sinus surgery. Expert Rev Respir Med 6:493–498
Mani G, Feldman MD, Patel D, Agrawal C (2007) Coronary stents: a materials perspective. Biomaterials 28:1689–1710
Geller J (2011) CDRH issues nonapproval letter to EES for SEDASYS system. J Clin Eng 36:88–91
Chevalier X, Jerosch J, Goupille P, van Dijk N, Luyten FP, Scott DL et al (2010) Single, intra-articular treatment with 6 ml hylan GF 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis 69:113–119
Nagele H, Azizi M, Hashagen S, Castel MA, Behrens S (2007) First experience with a new active fixation coronary sinus lead. Europace 9:437–441
Junkins-Hopkins JM (2011) Biologic dressings. J Am Acad Dermatol 64:e5–e7
Glassman SD, Carreon L, Djurasovic M, Campbell MJ, Puno RM, Johnson JR et al (2007) Posterolateral lumbar spine fusion with INFUSE bone graft. Spine J 7:44–49
Young VL, Boswell CB, Centeno RF, Watson ME (2005) DMSO: applications in plastic surgery. Aesthet Surg J 25:201–209
Jordan WD Jr, Moore WM Jr, Melton JG, Brown OW, Carpenter JP (2009) Secure fixation following EVAR with the Powerlink XL System in wide aortic necks: results of a prospective, multicenter trial. J Vasc Surg 50:979
Pagnano M, Westrich G (2005) Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans. Osteoarthritis Cartilage 13:751–761
Glogau RG (2012) Fillers: from the past to the future. Semin Cutan Med Surg 31:78–87
Chau M, Patterson ME, Yi S, Geist S, Oba T. (2012) Prosthetic apparatus for implantation at mitral valve. US Patent 20,120,323,316
Kablik J, Monheit GD, Yu L, Chang G, Gershkovich J (2009) Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg 35:302–312
Altman RD (2010) Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee. Expert Rev Clin Immunol 6:21–27
Roten L, Stortecky S, Scarcia F, Kadner A, Tanner H, Delacretaz E et al (2012) Atrioventricular conduction after transcatheter aortic valve implantation and surgical aortic valve replacement. J Cardiovasc Electrophysiol 23:1115–1122
Klijian A (2012) A novel approach to control air leaks in complex lung surgery: a retrospective review. J Cardiothorac Surg 7:49–55
Burgess CM (2008) Treatment of facial asymmetry with poly-L-lactic acid: a case study. Aesthetic Plast Surg 32:552–554
Shoshani D, Markovitz E, Cohen Y, Heremans A, Goldlust A (2007) Skin test hypersensitivity study of a cross linked, porcine collagen implant for aesthetic surgery. Dermatol Surg 33:S152–S158
Jamieson WRE, Koerfer R, Yankah CA, Zittermann A, Hayden RI, Ling H et al (2009) Mitroflow aortic pericardial bioprosthesis-clinical performance. Eur J Cardiothorac Surg 36:818–824
Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG Jr, Shank RC et al (2009) Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. Int J Toxicol 28:5–67
Busso M, Voigts R (2008) An investigation of changes in physical properties of injectable calcium hydroxylapatite in a carrier gel when mixed with lidocaine and with lidocaine/epinephrine. Dermatol Surg 34:S16–S24
Spear SL, Parikh PM, Reisin E, Menon NG (2008) Acellular dermis-assisted breast reconstruction. Aesthetic Plast Surg 32:418–425
Cohen SR, Berner CF, Busso M, Gleason MC, Hamilton D, Holmes RE et al (2006) ArteFill: a long-lasting injectable wrinkle filler material-summary of the US Food and Drug Administration trials and a progress report on 4-to 5-year outcomes. Plast Reconstr Surg 118:64S–76S
Suman T (2011) Enhancing facial esthetics by other modalities. Int J Dent 2011:1–6
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Controlled Release Society
About this chapter
Cite this chapter
Khan, W., Muntimadugu, E., Jaffe, M., Domb, A.J. (2014). Implantable Medical Devices. In: Domb, A., Khan, W. (eds) Focal Controlled Drug Delivery. Advances in Delivery Science and Technology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-9434-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9434-8_2
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-9433-1
Online ISBN: 978-1-4614-9434-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)